{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-104363","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.326183+00:00","generated_at":"2026-05-17T18:18:36.248235+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LifeStance Q2 revenue $345.3M (+11% YoY); raises FY 2025 Adj. EBITDA guidance to $140-150M","bullets":["Revenue of $345.3M (+11% YoY); net loss narrowed to $3.8M from $23.3M.","Adjusted EBITDA of $34.0M (+19% YoY); Free Cash Flow of $56.6M, a quarterly record.","Clinician base grew 11% to 7,708 (net +173 in Q2); visit volumes up 12% to 2.2M.","FY 2025 guidance: Adj. EBITDA raised to $140-150M (midpoint +$5M); revenue reiterated $1.40-1.44B.","Q3 2025 guidance: revenue $345-365M, Adj. EBITDA $33-39M, Center Margin $105-119M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-104363","json":"https://secwatch.observer/filing/0000950170-25-104363.json","markdown":"https://secwatch.observer/filing/0000950170-25-104363.md","text":"https://secwatch.observer/filing/0000950170-25-104363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/0000950170-25-104363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/lfst-20250807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:18:36.248235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}